Back to Agenda
Session 7: Convergence & Reliance
Session Chair(s)
Susanne Ausborn, PHD
Global Head International Regulatory Policy, Roche, Switzerland
Frank Montgomery, PHD
Global Head Regulatory CMC, GRAPSQA, AstraZeneca, United Kingdom
This Workshop will bring together regulators from different national/regional/global bodies and industry to discuss ongoing and future efforts to drive regional and global regulatory convergence. WHO has rolled out their Good Regulatory Practice and Good Reliance Practice guidelines and there are numerous examples around the world where regulatory reliance pathways, work-sharing and recognition have been established and/or are further developed. But more needs to be done to enable efficient and effective responses to public health emergencies and beyond.
Panellists from Regulatory Agencies and Industry representatives will share their experiences with different "working models" and reflect on the value of collaboration, what to take further from the learnings from the Pandemic and how to address existing barriers to ensure timely and continuous supply of medicines to patients in need around the globe.
Learning Objective : At the conclusion of this session, participants should be able to:
- Contribute to the establishment of a best practices framework for managing regulatory information and processes
- Understand the benefit and structure of the RIM Reference Model and apply the structure, content, and nomenclature to RIM planning, design and implementation activities
- Provide input to DIA RIM AI Use Cases
Speaker(s)
Samvel Azatyan, MD, PHD
Senior Adviser, Council For International Organizations of Medical Sciences (CIOMS), Switzerland
Reflections from WHO
Nawaf Matar Almutairi, MPHARM
Regulatory Affairs Expert , Saudi Food and Drug Authority , Saudi Arabia
Reflections from Global Health Authorities on Convergence and Reliance
Dmitriy Rozdestvensky, MD, PHD
Head, Division for Coordination of Common Market for Drugs and Medical Devices F, Eurasian Economic Commission, Russian Federation
Raphael Sanches Pereira
General Manager of the Office for Medicines, ANVISA, Brazil
Reflections from Global Health Authorities on Convergence and Reliance
Isabelle Colmagne-Poulard, PHARMD, MBA, MSC
Head, International Global Regulatory & Scientific Policy, Merck, Switzerland
Reflections from Industry on Convergence and Reliance
Jinesh Patel, PHD, MS, RPH
Associate Director, Regulatory Strategy, Vertex Pharmaceuticals, United Kingdom
Recent Successes in the use of WHO Reliance processes in MA and PAC: AZ perspective
Have an account?